Tier 2 — strong

Creatine but not betaine supplementation increases muscle phosphorylcreatine content and strength performance

Serena del Favero, Hamilton Roschel, Guilherme Artioli, Carlos Ugrinowitsch, Valmor Tricoli, André Costa, Renato Barroso, Ana Lua Negrelli, Maria Concepción Otaduy, Cláudia da Costa Leite, Antonio Herbert Lancha-Junior, Bruno Gualano
Amino acids 2012 42(6):2299-2305

Bibliography

PubMed
PMID 21744011
Funding
Funding was not specified in the indexed record or accessible funding metadata.
Competing interests
A competing-interest declaration was not available in the indexed record or accessible disclosure metadata.

Study snapshot

DesignRandomized controlled trial
ModelHuman participants
SampleUntrained adults; total sample not stated in the indexed abstract
InterventionBetaine 2 g/day, creatine 20 g/day, their combination or placebo
Duration10 days
EndpointsMuscle phosphocreatine; Strength; Power

What the study showed, in plain terms

Published in 2012, this source examined exercise performance and body composition. Design: Randomized controlled trial. Sample/model: Untrained adults; total sample not stated in the indexed abstract. The exposure or intervention was Betaine 2 g/day, creatine 20 g/day, their combination or placebo. Follow-up or treatment period: 10 days.

Creatine increased muscle phosphocreatine and selected strength/power measures. Betaine alone did not, and adding it to creatine did not provide a clear extra benefit.

Short loading study in untrained participants; no evidence here that betaine reproduces creatine's effects.

Continue with TMG Data Center

Continue with Betaine Anhydrous Pre-Workout: Performance, Dose and Evidence

Key findings

  • Creatine increased muscle phosphocreatine and selected strength/power measures.
  • Betaine alone did not, and adding it to creatine did not provide a clear extra benefit.
  • The recorded outcome domains were Muscle phosphocreatine; Strength; Power.
  • The result applies to the tested exposure: Betaine 2 g/day, creatine 20 g/day, their combination or placebo; 10 days.

What this study can and cannot tell us

  • Short loading study in untrained participants; no evidence here that betaine reproduces creatine's effects.
  • An individual controlled trial must be interpreted alongside its comparator, sample size, endpoint selection and independent replication. It does not validate a different commercial formulation or a general longevity claim.
  • Source basis: Indexed abstract and bibliographic data. Missing method details, funding information or participant denominators are not inferred.

Citation network

Articles citing this research paper

2 articles

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified